Published on 10 Jun 2021 on Benzinga via Yahoo Finance
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness.
The earnings news flow was confined to micro- and small-cap companies. Five biopharma companies listed their shares on the Nasdaq through initial public offerings. These companies raised about $666.5 million in gross proceeds.